Results 151 to 160 of about 59,251 (307)

Role of S1P‐ and Rho‐kinase signalling in age‐related myogenic tone deficiency in murine resistance arteries

open access: yesExperimental Physiology, EarlyView.
Abstract Ageing is a risk factor for cardiovascular and neurodegenerative diseases. The myogenic response in resistance arteries is responsible for basal (myogenic) tone and blood flow autoregulation. G‐protein‐coupled receptors and G12/RhoA/Rho kinase are implicated in myogenic tone (MT), and we aimed to clarify their role in pressure sensing and ...
Gry Freja Skovsted   +11 more
wiley   +1 more source

Neurohormonal modulation: The new paradigm of pharmacological treatment of heart failure

open access: yesRevista Portuguesa de Cardiologia, 2019
The current paradigm of medical therapy for heart failure with reduced ejection fraction (HFrEF) is triple neurohormonal blockade with an angiotensin-converting enzyme inhibitor (ACEI), a beta-blocker (BB) and a mineralocorticoid receptor antagonist (MRA)
J. Silva-Cardoso   +10 more
doaj   +1 more source

Cardiac remodelling in type 2 diabetes: Pathophysiological mechanisms and opportunities for multiscale computational modelling and simulation

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Overview of multiscale cardiac remodelling in type 2 diabetes and how to model and simulate these changes using a human‐based, multiscale computational framework. Cardiac remodelling in type 2 diabetes occurs at ionic channel, protein, cellular, tissue and whole‐organ level, affecting the electrophysiological function, mechanical
Ambre Bertrand   +2 more
wiley   +1 more source

Sacubitril/valsartan improved microvascular endothelial function in a young patient with COVID-19-related mild left ventricular dysfunction

open access: diamond, 2022
Marcin Hellmann   +6 more
openalex   +2 more sources

Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM‐HF trial

open access: yesEuropean Journal of Heart Failure, 2019
To assess differences in diuretic dose requirements in patients treated with sacubitril/valsartan compared with enalapril in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure (PARADIGM‐HF)
O. Vardeny   +11 more
semanticscholar   +1 more source

Formulation, in-vitro evaluation and optimization of valsartan nano-lipid complex by Box-Behnken design

open access: diamond, 2023
Magdy I. Mohamed   +5 more
openalex   +1 more source

Olmesartan‐induced gastritis with no lower gastrointestinal symptoms: A case report

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
Abstract A 74‐year‐old man with decreased appetite, weight, and heartburn was referred to our hospital. His medications included olmesartan. Esophagogastroduodenoscopy (EGD) revealed antral‐dominant erosive gastritis and nodular mucosa. A gastric biopsy revealed inflammatory cell infiltration.
Satoshi Kosaka   +2 more
wiley   +1 more source

Influence of Mrp2 C24t Genetic Variant on The Pharmacokinetics of Valsartan [PDF]

open access: bronze, 2015
Hyun‐Sub Lee   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy